Clinical trial
Effect of Enteral Administration of Docosahexaenoic Acid on Development of the Retinopathy of Prematurity
NCT02683317 is registered in ClinicalTrials.gov with Coordinación de Investigación en Salud, Mexico as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Enteral Administration of Docosahexaenoic Acid on Development of the Retinopathy of Prematurity
- Lead sponsor
- Coordinación de Investigación en Salud, Mexico
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 22, 2016
- Completion date
- October 31, 2017
- Enrollment
- 110 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.